Hirsutism Medications

2/0.035mg

Formulated to treat androgen-dependent skin conditions; indicated to alleviate symptoms of severe acne in women.

2/0.035mg

developed to target androgen-mediated skin conditions, to alleviate acne symptoms.

13.9%

Indicated to mitigate facial hirsutism and formulated to target excessive hair growth.

13.9%

indicated to support the reduction of unwanted facial hair growth in women.